List of Excipients in API dabigatran etexilate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dabigatran etexilate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | ACACIA | |
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | DIMETHICONE | |
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | HYDROXYPROPYL CELLULOSE | |
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dabigatran etexilate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 | AMMONIA |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 | FERRIC OXIDE RED |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 | FERRIC OXIDE YELLOW |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 | FERROSOFERRIC OXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dabigatran etexilate
Excipient focus: ACACIA
dabigatran etexilate drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
dabigatran etexilate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
dabigatran etexilate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
dabigatran etexilate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
dabigatran etexilate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
dabigatran etexilate drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dabigatran etexilate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
dabigatran etexilate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
dabigatran etexilate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| Novadoz Pharmaceuticals LLC | dabigatran etexilate | 72205-202 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
dabigatran etexilate drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
dabigatran etexilate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
dabigatran etexilate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
dabigatran etexilate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
dabigatran etexilate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
dabigatran etexilate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
dabigatran etexilate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dabigatran etexilate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
dabigatran etexilate drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
dabigatran etexilate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
dabigatran etexilate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Novadoz Pharmaceuticals LLC | dabigatran etexilate | 72205-202 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
dabigatran etexilate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | dabigatran etexilate | 42291-034 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| Novadoz Pharmaceuticals LLC | dabigatran etexilate | 72205-202 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE PHTHALATE
dabigatran etexilate drug variants containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dabigatran etexilate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
dabigatran etexilate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dabigatran etexilate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| Novadoz Pharmaceuticals LLC | dabigatran etexilate | 72205-202 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dabigatran etexilate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dabigatran etexilate drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
dabigatran etexilate drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
dabigatran etexilate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 600
dabigatran etexilate drug variants containing POLYETHYLENE GLYCOL 600
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYETHYLENE GLYCOL 600
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
dabigatran etexilate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
dabigatran etexilate drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
dabigatran etexilate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
dabigatran etexilate drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
dabigatran etexilate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
dabigatran etexilate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dabigatran etexilate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
dabigatran etexilate drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
dabigatran etexilate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
dabigatran etexilate drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
dabigatran etexilate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
dabigatran etexilate drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dabigatran etexilate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dabigatran etexilate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
